Qualifying Conditions

A patient may only register for a medical marijuana certificate if he or she is a Connecticut resident being treated for
a qualifying medical condition by a Connecticut-licensed DCP registered physician.

Qualifying Medical Conditions include:

  • Cancer
  • Glaucoma
  • Positive Status for Human Immunodeficiency Virus or Acquired Immune Deficiency Syndrome
  • Parkinson’s Disease
  • Multiple Sclerosis
  • Damage to the Nervous Tissue of the Spinal Cord with Objective Neurological Indication of Intractable Spasticity
  • Epilepsy
  • Cachexia
  • Wasting Syndrome
  • Crohn’s Disease
  • Post-Traumatic Stress Disorder
  • Sickle Cell Disease
  • Post Laminectomy Syndrome with Chronic Radiculopathy
  • Severe Psoriasis and Psoriatic Arthritis
  • Amyotrophic Lateral Sclerosis
  • Ulcerative Colitis
  • Complex Regional Pain Syndrome
  • HIV, AIDS, ALS
conditionsimg

New Qualifying Medical Conditions – Effective October 1, 2016:

Patients 18 years of age or older:
  • Cerebral Palsy
  • Cystic Fibrosis
  • Irreversible Spinal Cord Injury with Objective Neurological Indication of Intractable Spasticity
  • Terminal Illness Requiring End-Of-Life Care
  • Uncontrolled Intractable Seizure Disorder
  • Spasticity or Neuropathic Pain Associated with Fibromyalgia (Effective 2018)*
  • Severe Rheumatoid Arthritis (Effective 2018)*
  • Post Herpetic Neuralgia (Effective 2018)*
  • Hydrocephalus with Intractable Headache (Effective 2018)*
  • Intractable Headache Syndromes (Effective 2018)*
  • Neuropathic Facial Pain (Effective 2018)*
  • Muscular Dystrophy (Effective 2018)*
  • Osteogenesis Imperfecta (Effective 2018)*
  • Chronic Neuropathic Pain Associated with Degenerative Spinal Disorders (Effective 2018)*
Patients less than 18 years of age:
  • Cerebral Palsy
  • Cystic Fibrosis
  • Irreversible Spinal Cord Injury with Objective Neurological Indication of Intractable Spasticity
  • Severe Epilepsy
  • Terminal Illness Requiring End-Of-Life Care
  • Uncontrolled Intractable Seizure Disorder
  • Muscular Dystrophy (Effective 2018)*
  • Osteogenesis Imperfecta (Effective 2018)*